← All posts Healthy aging

Healthy aging on a GLP-1: muscle, energy and NAD+ explained

By Juvenate Editorial Published Last updated

Healthy aging on a GLP-1: muscle, energy and NAD+ explained

Losing a lot of weight in your forties, fifties, or sixties raises a fair question: will I come out the other side stronger, or just smaller? The trials give a useful answer for muscle, bone, energy, and sleep. For NAD+ supplements, the honest answer is shorter: they raise a number in the blood, and the human benefits are still unproven.

This is not medical advice. It does not tell you what to take or how much. Talk with the clinician who prescribed your GLP-1 before you add a supplement, start a new exercise plan, or change your medicine. No affiliate links. Disclosure.

What “healthy aging” means on a GLP-1

No pill reverses aging, and this page will not pretend otherwise. Here it means keeping strong legs, solid bones, steady energy, decent sleep, and skin you feel okay in. A GLP-1 medicine can help with some of these by lowering weight. It can also make some of them harder if the weight comes off without a plan. The good news is that the most useful steps are ordinary ones.

Muscle: you lose some, and you can protect it

When people lose a lot of weight by any method, part of what leaves is lean tissue, which includes muscle. The clearest public numbers for semaglutide come from a body-scan substudy of the STEP 1 trial. In 140 people, total fat mass fell about 19% and total lean mass fell about 10% over 68 weeks. Fat dropped faster than lean tissue, so lean mass actually became a larger share of body weight. The protein guide walks through those numbers and why this site does not assign a gram target.

Lean loss matters more as we age, because muscle is what gets you up stairs and out of a chair. Two things protect it, and neither comes in a bottle: enough protein when appetite allows, and using your muscles against resistance. The CDC’s guidance for adults 65 and older calls for muscle-strengthening work on at least two days a week, plus aerobic activity and balance practice. It also says that if you cannot meet the full target, some activity is better than none. Bands, light weights, or controlled sit-to-stands all count. Ask before you add load if you have heart disease, joint problems, or get dizzy on your medicine.

Bone: exercise made the difference in one trial

Bone is the quieter half of this story. Weight loss in general tends to come with some bone loss, which is a bigger concern after menopause and in older adults.

A randomized trial from Copenhagen, published in JAMA Network Open in 2024, is one of the few that tested a GLP-1 medicine with and without exercise. After an initial diet, 195 adults with obesity were assigned to one year of exercise, the GLP-1 drug liraglutide, both, or placebo. The medicine alone lowered bone density at the hip and spine compared with exercise alone, even though weight loss was similar. The group that combined the medicine with exercise lost the most weight, about 17 kilograms over the whole study, and their hip and spine bone density was not different from placebo. The exercise was real work: indoor cycling and circuit training, a few times a week.

Read it with care. This was liraglutide, an older daily GLP-1, in adults aged 18 to 65 without diabetes, and the authors call the bone results exploratory. It does not prove the same for semaglutide or tirzepatide. It does point the same direction as the muscle data: moving your body is part of the treatment, not an extra.

Energy: tired is common, and it deserves a look

Fatigue is a listed side effect, not your imagination. In the Wegovy prescribing information, fatigue was reported by 11% of adults on the medicine and 5% on placebo. Zepbound’s labeling lists fatigue among its side effects too.

Some everyday reasons can stack up when appetite drops: eating too little overall, too little protein, not enough fluids, or losing sleep to nausea or reflux. Those are worth raising with your prescriber, who can look at your dose, the pace of your weight loss, and your blood work. Ongoing exhaustion, dizziness, or feeling faint is a reason to call, not something to push through. Shedding hair can show up in the same months, and the hair loss guide covers why.

Sleep: one GLP-1 now has an approval for sleep apnea

Extra weight and obstructive sleep apnea often travel together. In December 2024, FDA approved Zepbound (tirzepatide) for moderate to severe obstructive sleep apnea in adults with obesity, used with diet and physical activity. The approval was based on two 52-week trials in 469 adults. People on the medicine had fewer breathing interruptions per hour of sleep than people on placebo, and FDA said the improvement is likely related to weight loss.

That approval is specific. It does not mean every GLP-1 treats sleep apnea, and it does not replace a sleep study or a CPAP machine your doctor has prescribed. If you snore loudly, wake up gasping, or feel sleepy all day, tell your prescriber.

Skin: weight loss shows in the face

Faster or larger weight loss can make the face look thinner or older, the change people call “Ozempic face.” It mostly reflects lost facial fat volume. The skin guide explains what is going on and which options are worth a conversation with a dermatologist. If you are curious about collagen powders or peptide creams, the peptides guide separates ordinary skincare from injectable “research peptides,” which this site does not recommend.

NAD+ and its precursors: what human studies show

NAD+ (nicotinamide adenine dinucleotide) is a molecule cells use to turn food into energy and to run repair enzymes. Its levels seem to fall with age in some tissues. In mice, raising NAD+ with precursors such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), both forms of vitamin B3, improved several measures of aging. That is why the supplements exist. The question is what happens in people.

What the human trials do show. A 2023 review in the Journals of Gerontology, written by researchers who study these compounds, sums it up: NR and NMN are safe and well tolerated in the trials so far, and they can raise NAD+ and related molecules in the blood and some tissues. In a 2018 crossover trial in healthy adults aged 55 to 79, NR raised NAD+ in blood cells by about 60% over six weeks, with no serious side effects. In a 2021 Science trial of 25 postmenopausal women with prediabetes and overweight or obesity, NMN improved how well muscle responded to insulin after 10 weeks.

What they don’t show. That same NMN trial found no change in body composition, blood sugar, blood pressure, or cholesterol. In 40 men with obesity and insulin resistance, 12 weeks of NR did not improve insulin sensitivity, energy expenditure, or body composition. In 12 men in their 70s, three weeks of NR raised some NAD+-related molecules in muscle but did not raise muscle NAD+ itself and did not change muscle energy production or grip strength. The blood pressure hints in the 2018 trial were exploratory and did not hold up after statistical correction. The review’s overall verdict is that most trials are small and short, results are inconsistent, and only limited data show clinically meaningful benefits.

Raising a molecule in the blood is not the same as living longer, feeling more energetic, or keeping more muscle. We found no published trial showing that an NAD+ supplement preserves muscle or bone during GLP-1 weight loss, or one that tested that question directly.

Where they stand legally. NR and NMN are sold as dietary supplements, which FDA does not approve for safety or effectiveness before sale. FDA said in 2022 that NMN could not be sold as a supplement. In September 2025 it reversed that position, and NMN is again lawful in supplements. That is a legal decision, not proof that it works.

If you are curious, the reasonable move is to treat NAD+ products as an unproven extra, not as a replacement for protein, strength work, and sleep. Bring the label to your prescriber or pharmacist and ask about interactions with your other medicines. This page will not suggest an amount. Be wary of NAD+ sold as injections or IV drips with big anti-aging promises. The trials above did not test them.

The short version

  1. Expect some lean and bone loss with big weight loss, and fight it with protein and resistance exercise your clinician has okayed.
  2. Fatigue is a real side effect, so report it rather than tough it out.
  3. Sleep problems are worth raising, especially snoring and daytime sleepiness.
  4. NAD+ supplements look safe in short studies and raise blood levels, but human benefits are not established.

Sources

  1. Wilding JPH, et al. Impact of semaglutide on body composition in adults with overweight or obesity: exploratory analysis of the STEP 1 study. J Endocr Soc. 2021. PubMed Central.
  2. Centers for Disease Control and Prevention. Older adult activity: an overview. Updated December 4, 2025. CDC.
  3. Jensen SBK, et al. Bone health after exercise alone, GLP-1 receptor agonist treatment, or combination treatment: a secondary analysis of a randomized clinical trial. JAMA Netw Open. 2024;7(6):e2416775. JAMA Network Open.
  4. Novo Nordisk. Wegovy (semaglutide) prescribing information, adverse reactions. DailyMed.
  5. U.S. Food and Drug Administration. FDA approves first medication for obstructive sleep apnea. December 20, 2024. FDA.
  6. Freeberg KA, et al. Dietary supplementation with NAD+-boosting compounds in humans: current knowledge and future directions. J Gerontol A Biol Sci Med Sci. 2023;78(12):2435-2448. PubMed Central.
  7. Martens CR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018;9:1286. PubMed Central.
  8. Yoshino M, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372(6547):1224-1229. PubMed Central.
  9. Dollerup OL, et al. A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects. Am J Clin Nutr. 2018;108(2):343-353. Europe PMC.
  10. Elhassan YS, et al. Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome and induces transcriptomic and anti-inflammatory signatures. Cell Rep. 2019;28(7):1717-1728. PubMed Central.
  11. Daniells S. FDA declares NMN lawful in dietary supplements. NutraIngredients. September 30, 2025. NutraIngredients.

If you are sorting a symptom, not a supplement

Not sure which of these fits you? The side-effect check points you to the right guide. It does not clear a supplement. How this site will handle any future affiliate link is on the disclosure page. There are none here.